PHG vs. HOLX, GEHC, ILMN, GMAB, STE, WAT, ALNY, COO, BAX, and BNTX
Should you be buying Koninklijke Philips stock or one of its competitors? The main competitors of Koninklijke Philips include Hologic (HOLX), GE HealthCare Technologies (GEHC), Illumina (ILMN), Genmab A/S (GMAB), STERIS (STE), Waters (WAT), Alnylam Pharmaceuticals (ALNY), Cooper Companies (COO), Baxter International (BAX), and BioNTech (BNTX). These companies are all part of the "medical" sector.
Hologic (NASDAQ:HOLX) and Koninklijke Philips (NYSE:PHG) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.
94.7% of Hologic shares are owned by institutional investors. Comparatively, 13.7% of Koninklijke Philips shares are owned by institutional investors. 1.8% of Hologic shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
In the previous week, Hologic had 2 more articles in the media than Koninklijke Philips. MarketBeat recorded 8 mentions for Hologic and 6 mentions for Koninklijke Philips. Koninklijke Philips' average media sentiment score of 0.97 beat Hologic's score of 0.17 indicating that Hologic is being referred to more favorably in the media.
Hologic has higher earnings, but lower revenue than Koninklijke Philips. Koninklijke Philips is trading at a lower price-to-earnings ratio than Hologic, indicating that it is currently the more affordable of the two stocks.
Hologic has a beta of 1, indicating that its share price has a similar volatility profile to the S&P 500.Comparatively, Koninklijke Philips has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500.
Hologic has a net margin of 12.98% compared to Hologic's net margin of -2.53%. Koninklijke Philips' return on equity of 18.91% beat Hologic's return on equity.
Hologic received 480 more outperform votes than Koninklijke Philips when rated by MarketBeat users. Likewise, 69.66% of users gave Hologic an outperform vote while only 56.97% of users gave Koninklijke Philips an outperform vote.
Hologic currently has a consensus price target of $87.00, indicating a potential upside of 14.50%. Given Koninklijke Philips' stronger consensus rating and higher possible upside, analysts plainly believe Hologic is more favorable than Koninklijke Philips.
Summary
Hologic beats Koninklijke Philips on 17 of the 18 factors compared between the two stocks.
Get Koninklijke Philips News Delivered to You Automatically
Sign up to receive the latest news and ratings for PHG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PHG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Koninklijke Philips Competitors List
Related Companies and Tools
